Martijn A. Spruit
Research Subjects
Martijn A. Spruit has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Daisy J. A. Janssen
Department of Health Services Research, Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands
3 shared publications Emiel F.M. Wouters
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, and
3 shared publications- Emiel F. M. Wouters
Ludwig Boltzmann Institute for Lung Health, 1140 Vienna, Austria
2 shared publications - J. M. G. A. Schols
Nursing Home Physician, Vivre Group, Polvertorenstraat 6, 6211 LX Maastricht, The Netherlands
2 shared publications Paul P. Janssen
2 shared publicationsBartolome R Celli
1 shared publication
Latest Publications
- 1 June 2010
- Published by Elsevier in Respiratory Medicine
- Vol. 104 (6) , 849-857
Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort
- 1 June 2010
- Published by Elsevier in Respiratory Medicine
- Vol. 104 (6) , 849-857
Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort
- Open Access
- 28 April 2010
- Published by Springer Nature in BMC Palliative Care
- Vol. 9 (1) , 6
End-of-life care in a COPD patient awaiting lung transplantation: a case report
COPD is nowadays the main indication for lung transplantation. In appropriately selected patients with end stage COPD, lung transplantation may improve quality of life and prognosis of survival. However, patients with end stage COPD may die while waiting for lung transplantation. Palliative care is important to address the needs of patients with end stage COPD. This case report shows that in a patient with end stage COPD listed for lung transplantation offering palliative care and curative-restorative care concurrently may be problematic. If the requirements to remain a transplantation candidate need to be met, the possibilities for palliative care may be limited. Discussing the possibilities of palliative care and the patient's treatment preferences is necessary to prevent that end-of-life care needs of COPD patients dying while listed for lung transplantation are not optimally addressed. The patient's end-of-life care preferences may ask for a clear distinction between the period in which palliative and curative-restorative care are offered concurrently and the end-of-life care period. This may be necessary to allow a patient to spend the last stage of life according to his or her wishes, even when this implicates that lung transplantation is not possible anymore and the patient will die because of end stage COPD.
- 28 April 2010
- Published by Springer Nature in BMC Palliative Care
- Vol. 9 (1) , 6
Open AccessEnd-of-life care in a COPD patient awaiting lung transplantation: a case report
COPD is nowadays the main indication for lung transplantation. In appropriately selected patients with end stage COPD, lung transplantation may improve quality of life and prognosis of survival. However, patients with end stage COPD may die while waiting for lung transplantation. Palliative care is important to address the needs of patients with end stage COPD. This case report shows that in a patient with end stage COPD listed for lung transplantation offering palliative care and curative-restorative care concurrently may be problematic. If the requirements to remain a transplantation candidate need to be met, the possibilities for palliative care may be limited. Discussing the possibilities of palliative care and the patient's treatment preferences is necessary to prevent that end-of-life care needs of COPD patients dying while listed for lung transplantation are not optimally addressed. The patient's end-of-life care preferences may ask for a clear distinction between the period in which palliative and curative-restorative care are offered concurrently and the end-of-life care period. This may be necessary to allow a patient to spend the last stage of life according to his or her wishes, even when this implicates that lung transplantation is not possible anymore and the patient will die because of end stage COPD.
- 15 November 2009
- Published by Springer Nature
- p. 173-187
Exercise-Based Rehabilitation in Patients with Lung Cancer
- 15 November 2009
- Published by Springer Nature
- p. 173-187
Exercise-Based Rehabilitation in Patients with Lung Cancer
- 17 August 2009
- Published by Wiley in Respirology
- Vol. 14 (6) , 781-787
Rehabilitation and palliative care in lung fibrosis
The idiopathic interstitial pneumonias are a heterogeneous group of diffuse parenchymal lung diseases with varying degrees of inflammation and fibrosis, like interstitial pulmonary fibrosis. Functional exercise tolerance and quality of life have been shown to be significantly affected in patients with lung fibrosis. Moreover, interstitial pulmonary fibrosis is a progressive disease with poor prognosis and limited response to conventional pharmacological treatment like immunosuppressive agents. So, in patients with lung fibrosis there seems a clear indication to refer them for comprehensive pulmonary rehabilitation programmes and to initiate palliative care in an early phase of the disease. In the current review we will present a rationale for pulmonary rehabilitation in patients with lung fibrosis and the effects of this type of non‐pharmacological intervention on exercise capacity and quality of life. In addition, we will discuss possibilities for palliative care in these patients.
- 17 August 2009
- Published by Wiley in Respirology
- Vol. 14 (6) , 781-787
Rehabilitation and palliative care in lung fibrosis
The idiopathic interstitial pneumonias are a heterogeneous group of diffuse parenchymal lung diseases with varying degrees of inflammation and fibrosis, like interstitial pulmonary fibrosis. Functional exercise tolerance and quality of life have been shown to be significantly affected in patients with lung fibrosis. Moreover, interstitial pulmonary fibrosis is a progressive disease with poor prognosis and limited response to conventional pharmacological treatment like immunosuppressive agents. So, in patients with lung fibrosis there seems a clear indication to refer them for comprehensive pulmonary rehabilitation programmes and to initiate palliative care in an early phase of the disease. In the current review we will present a rationale for pulmonary rehabilitation in patients with lung fibrosis and the effects of this type of non‐pharmacological intervention on exercise capacity and quality of life. In addition, we will discuss possibilities for palliative care in these patients.
Effects of moderate-to-high intensity resistance training in patients with chronic heart failure
Context: Resistance training may be beneficial for patients with chronic heart failure (CHF). Objective: To systematically review the methodological quality of, and summarise the effects of, moderate-to-high intensity resistance training in CHF. Data sources: Medline/PubMed, Science Citation Index Expanded, SSCI and A&HCI. Study selection: English language (non-)randomised controlled trials. Data extraction: A predesigned data extraction form was used to obtain data on trial design and relevant results. Methodological quality of the identified trials were scored using the Delphi list. Results: Most of the 10 trials identified had moderate-to-severe methodological limitations. Effects of resistance training (alone or in combination with endurance training) are inconclusive for outcomes like exercise capacity and disease-specific quality of life. Conclusions: Even though moderate-to-high intensity resistance training does not seem be harmful for patients with CHF, the current peer-reviewed evidence seems inadequate to generally recommend incorporation of resistance training into exercise-based rehabilitation programmes for patients with CHF.
Effects of moderate-to-high intensity resistance training in patients with chronic heart failure
Context: Resistance training may be beneficial for patients with chronic heart failure (CHF). Objective: To systematically review the methodological quality of, and summarise the effects of, moderate-to-high intensity resistance training in CHF. Data sources: Medline/PubMed, Science Citation Index Expanded, SSCI and A&HCI. Study selection: English language (non-)randomised controlled trials. Data extraction: A predesigned data extraction form was used to obtain data on trial design and relevant results. Methodological quality of the identified trials were scored using the Delphi list. Results: Most of the 10 trials identified had moderate-to-severe methodological limitations. Effects of resistance training (alone or in combination with endurance training) are inconclusive for outcomes like exercise capacity and disease-specific quality of life. Conclusions: Even though moderate-to-high intensity resistance training does not seem be harmful for patients with CHF, the current peer-reviewed evidence seems inadequate to generally recommend incorporation of resistance training into exercise-based rehabilitation programmes for patients with CHF.
- Open Access
- 6 May 2008
- Published by Springer Nature in BMC Palliative Care
- Vol. 7 (1) , 5
Self-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol
Recent research shows that the prevalence of patients with very severe chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF) and chronic renal failure (CRF) continues to rise over the next years. Scientific studies concerning self-perceived symptoms and care needs in patients with severe to very severe COPD, CHF and CRF are scarce.
- 6 May 2008
- Published by Springer Nature in BMC Palliative Care
- Vol. 7 (1) , 5
Open AccessSelf-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol
Recent research shows that the prevalence of patients with very severe chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF) and chronic renal failure (CRF) continues to rise over the next years. Scientific studies concerning self-perceived symptoms and care needs in patients with severe to very severe COPD, CHF and CRF are scarce.
- 1 January 2008
- Published by Elsevier in The Lancet
- Vol. 371 (9606) , 12-13
Integration of pulmonary rehabilitation in COPD
- 1 January 2008
- Published by Elsevier in The Lancet
- Vol. 371 (9606) , 12-13
Integration of pulmonary rehabilitation in COPD
- 1 December 2007
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (12) , 2502-2510
Hypogonadism in male outpatients with sarcoidosis
- 1 December 2007
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (12) , 2502-2510
Hypogonadism in male outpatients with sarcoidosis
- 1 December 2007
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (12) , 2454-2463
Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade
- 1 December 2007
- Published by Elsevier in Respiratory Medicine
- Vol. 101 (12) , 2454-2463
Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade
- 1 January 2007
- Published by Springer Nature in Sports Medicine
- Vol. 37 (6) , 501-518
New Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
Pulmonary rehabilitation has been shown to be an important part of the management of patients with chronic obstructive pulmonary disease (COPD). Exercise training is the corner stone of a comprehensive, multidisciplinary pulmonary rehabilitation in COPD and has been shown to improve health-related quality of life and exercise capacity. Nevertheless, not every COPD patient responds well to pulmonary rehabilitation. Future trials should focus on new additions to conventional pulmonary rehabilitation programmes to optimise its effects on health-related quality of life, exercise capacity, body composition and muscle function in patients with COPD. Therefore, a patient-tailored approach is inevitable. Advantages and disadvantages of new modalities of pulmonary rehabilitation will be outlined in detail, including the following: endurance training and long-acting bronchodilatators; endurance training and technical modalities (inspiratory pressure support and inspiratory muscle training); interval training; resistance training; transcutaneous neuromuscular electrical stimulation; and exercise training and supplements (oxygen, oral creatine, anabolic steroids and polyunsaturated fatty acids). Based on well defined baseline characteristics, patients should most probably be individually selected. At present, these new modalities of pulmonary rehabilitation have been shown to improve body composition, skeletal muscle function and sometimes also exercise capacity. However, the translation to an improved health-related quality of life is mostly lacking, and cost effectiveness and long-term effects have not been studied. Moreover, future trials should study the effects of pulmonary rehabilitation in elderly patients with restrictive pulmonary diseases.
- 1 January 2007
- Published by Springer Nature in Sports Medicine
- Vol. 37 (6) , 501-518
New Modalities of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
Pulmonary rehabilitation has been shown to be an important part of the management of patients with chronic obstructive pulmonary disease (COPD). Exercise training is the corner stone of a comprehensive, multidisciplinary pulmonary rehabilitation in COPD and has been shown to improve health-related quality of life and exercise capacity. Nevertheless, not every COPD patient responds well to pulmonary rehabilitation. Future trials should focus on new additions to conventional pulmonary rehabilitation programmes to optimise its effects on health-related quality of life, exercise capacity, body composition and muscle function in patients with COPD. Therefore, a patient-tailored approach is inevitable. Advantages and disadvantages of new modalities of pulmonary rehabilitation will be outlined in detail, including the following: endurance training and long-acting bronchodilatators; endurance training and technical modalities (inspiratory pressure support and inspiratory muscle training); interval training; resistance training; transcutaneous neuromuscular electrical stimulation; and exercise training and supplements (oxygen, oral creatine, anabolic steroids and polyunsaturated fatty acids). Based on well defined baseline characteristics, patients should most probably be individually selected. At present, these new modalities of pulmonary rehabilitation have been shown to improve body composition, skeletal muscle function and sometimes also exercise capacity. However, the translation to an improved health-related quality of life is mostly lacking, and cost effectiveness and long-term effects have not been studied. Moreover, future trials should study the effects of pulmonary rehabilitation in elderly patients with restrictive pulmonary diseases.